Urabrelimab (SRF-231) is a humanized antibody targeting CD47, with antitumor activity. It blocks the CD47-SIRPalpha interaction and is used in studies of advanced malignant solid tumors.
Purity:
>95%
CAS Number:
[2249722-58-3]
Target:
Interleukin|||Others
* VAT and and shipping costs not included. Errors and price changes excepted